Increased risk of laboratory-confirmed and severe influenza in a contemporary cohort of well-treated persons with HIV compared with matched population controls

Background While influenza burden is increased among untreated persons with HIV (PWH), it is unclear if this also applies to well-treated PWH. We investigated the incidence of laboratory-confirmed influenza and severe influenza, i.e. influenza-associated hospitalization and death, in a contemporary cohort of virologically suppressed PWH and matched controls from the Danish general population, and whether HIV status was associated with these outcomes. Methods We included 1,005 virologically suppressed PWH from the Copenhagen Comorbidity in HIV Infection Study and 10,050 matched controls from the Copenhagen General Population Study. Outcome data were obtained from national registries. Incidence rates (IR) per 1,000 person-years (PY) and incidence rate ratios (IRR) were calculated, and cumulative incidences were estimated accounting for competing risks. Associations between HIV status and outcomes were explored using Fine-Gray models. Results Follow-up time was 6,286 PY in PWH and 60,596 PY in matched controls for laboratory-confirmed influenza, and 5,890 PY and 56,015 PY for severe influenza. The IRs per 1,000 PY of laboratory-confirmed influenza were 4.1 (95%CI 2.7-6.1) in PWH and 1.8 (95%CI 1.5-2.1) in controls (IRR 2.3, 95%CI 1.5-3.6, p<0.001). For severe influenza, IRs were 1.9 (95%CI 0.9-3.3) and 0.5 (95%CI 0.4-0.7), and IRR 3.6 (95%CI 1.8-7.2, p<0.001). In competing risk regression models, HIV status was associated with increased risk of laboratory-confirmed influenza (subdistribution hazard rate (sHR) 2.5, 95%CI: 1.6-3.8, p<0.001) and severe influenza (sHR 3.9, 95%CI: 2.0-7.8, p<0.001). Conclusions Even well-treated PWH have higher risk of laboratory-confirmed and severe influenza than the general population, highlighting the importance of preventive measures.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-11-18
DOI
https://doi.org/10.1093/ofid/ofag754
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Increased risk of laboratory-confirmed and severe influenza in a contemporary cohort of well-treated persons with HIV compared with matched population controls

Andreas Ronit, Shoaib Afzal, Dina Leth Møller, Andreas Dehlbæk Knudsen et al.
Open Forum Infectious Diseases
Influenza Virus Research Studies
article

Increased risk of laboratory-confirmed and severe influenza in a contemporary cohort of well-treated persons with HIV compared with matched population controls

Andreas Ronit, Shoaib Afzal, Dina Leth Møller, Andreas Dehlbæk Knudsen, Magnus Glindvad Ahlström, Susanne Dam Nielsen, Josefine Amalie Loft, Børge Grønne Nordestgaard, Thomas Benfield
article en

Abstract

Background While influenza burden is increased among untreated persons with HIV (PWH), it is unclear if this also applies to well-treated PWH. We investigated the incidence of laboratory-confirmed influenza and severe influenza, i.e. influenza-associated hospitalization and death, in a contemporary cohort of virologically suppressed PWH and matched controls from the Danish general population, and whether HIV status was associated with these outcomes. Methods We included 1,005 virologically suppressed PWH from the Copenhagen Comorbidity in HIV Infection Study and 10,050 matched controls from the Copenhagen General Population Study. Outcome data were obtained from national registries. Incidence rates (IR) per 1,000 person-years (PY) and incidence rate ratios (IRR) were calculated, and cumulative incidences were estimated accounting for competing risks. Associations between HIV status and outcomes were explored using Fine-Gray models. Results Follow-up time was 6,286 PY in PWH and 60,596 PY in matched controls for laboratory-confirmed influenza, and 5,890 PY and 56,015 PY for severe influenza. The IRs per 1,000 PY of laboratory-confirmed influenza were 4.1 (95%CI 2.7-6.1) in PWH and 1.8 (95%CI 1.5-2.1) in controls (IRR 2.3, 95%CI 1.5-3.6, p<0.001). For severe influenza, IRs were 1.9 (95%CI 0.9-3.3) and 0.5 (95%CI 0.4-0.7), and IRR 3.6 (95%CI 1.8-7.2, p<0.001). In competing risk regression models, HIV status was associated with increased risk of laboratory-confirmed influenza (subdistribution hazard rate (sHR) 2.5, 95%CI: 1.6-3.8, p<0.001) and severe influenza (sHR 3.9, 95%CI: 2.0-7.8, p<0.001). Conclusions Even well-treated PWH have higher risk of laboratory-confirmed and severe influenza than the general population, highlighting the importance of preventive measures.

Open Forum Infectious Diseases
University of Copenhagen (DK), Herlev Hospital (DK), Hvidovre Hospital (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK)
Amgen, Eli Lilly and Company, AstraZeneca, Sanofi, Gilead Sciences, Amarin Corporation, Moderna, Novo Nordisk, Rigshospitalet, Region Hovedstaden, Shionogi, Svend Andersen Fonden, Esperion Therapeutics
Good health and well-being
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon